← Leaderboards
Aguirre A De Cubas
Vanderbilt University Medical Center
$599,834
Attributed
$599,834
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $124.2K · FY2020–24$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$599,834 · 1
By mechanism
K01$599,834 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Jeffrey C Rathmell$23,426,807
- Yuval Dor$525,377
- Erez Levanon$525,377
- Ruhee Dere$948,658
- Frank M Mason$653,671
Others in their field
Other Emerging Leaders on “Endogenous Retroviruses”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Tao Yang · Van Andel Research Institute$3,424,841
- Jonathan J Miner · University Of Pennsylvania$2,381,292
- Ron E Banks · University Of Oklahoma Hlth Sciences Ctr$2,230,925
- Farah Bakhshian Rahmatpanah · University Of California-Irvine$2,185,242
- Edward Bo-Yi Chuong · University Of Colorado$2,019,265
Research focus
Endogenous RetrovirusesEpigenetic ProcessEducational WorkshopDna Transposable ElementsDoctor Of PhilosophyElementsAnti-Ctla4Anti-CancerAntigen PresentationDesignAnti-Pd-L1CaliberCancer TherapyCareerCareer DevelopmentCell LineCell PhysiologyChromatin ImmunoprecipitationClear Cell Renal Cell CarcinomaClinical ApplicationClinical TrialsComputational BiologyBioinformaticsEpigenetic Therapy
Grant awards (5)
Activation of transposable elements as an endogenous source of neoepitopes and mediators of tumor immunogenicity$111,829
K01 · FY2024 · CA · contact PI
Activation of transposable elements as an endogenous source of neoepitopes and mediators of tumor immunogenicity$119,780
K01 · FY2023 · CA · contact PI
Activation of transposable elements as an endogenous source of neoepitopes and mediators of tumor immunogenicity$120,014
K01 · FY2022 · CA · contact PI
Activation of transposable elements as an endogenous source of neoepitopes and mediators of tumor immunogenicity$123,993
K01 · FY2021 · CA · contact PI
Activation of transposable elements as an endogenous source of neoepitopes and mediators of tumor immunogenicity$124,218
K01 · FY2020 · CA · contact PI